FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
出版年份 2016 全文链接
标题
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 115, Issue 10, Pages 1223-1233
出版商
Springer Nature
发表日期
2016-09-30
DOI
10.1038/bjc.2016.313
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells
- (2015) Hisato Kawakami et al. Oncotarget
- Biomarkers for Predicting the Efficacy of Anti-Epidermal Growth Factor Receptor Antibody in the Treatment of Colorectal Cancer
- (2014) Yasuyuki Okada et al. DIGESTION
- Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A
- (2013) Aldo Germani et al. CANCER LETTERS
- Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
- (2013) Paul Roepman et al. INTERNATIONAL JOURNAL OF CANCER
- Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
- (2013) Eva Budinska et al. JOURNAL OF PATHOLOGY
- Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
- (2013) Felipe De Sousa E Melo et al. NATURE MEDICINE
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy
- (2012) Salome Paillas et al. Autophagy
- Phosphorylation of P68 RNA Helicase by P38 MAP kinase contributes to colon cancer cells apoptosis induced by oxaliplatin
- (2012) Heena Dey et al. BMC CELL BIOLOGY
- Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
- (2012) Andreas Schlicker et al. BMC Medical Genomics
- Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response
- (2012) Valentina Grossi et al. CANCER BIOLOGY & THERAPY
- Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models
- (2012) Fulvio Chiacchiera et al. CANCER LETTERS
- Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
- (2012) Clara Montagut et al. NATURE MEDICINE
- Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A
- (2012) Shyamala Ganesan et al. THORAX
- Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin
- (2011) Ka-Kei Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
- (2010) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- The Extending Network of FOXO Transcriptional Target Genes
- (2010) Kristan E. van der Vos et al. ANTIOXIDANTS & REDOX SIGNALING
- Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients
- (2010) C Montagut et al. BRITISH JOURNAL OF CANCER
- Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38
- (2010) Céline Gongora et al. CANCER BIOLOGY & THERAPY
- Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma
- (2010) S. Paillas et al. CANCER RESEARCH
- Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells
- (2010) Huei-Fang Liu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase
- (2009) Kenji Takeuchi et al. FEBS Journal
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells
- (2008) Shu-Jun Chiu et al. TOXICOLOGY LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started